
Spectrum Pharmaceuticals SPPI
Quartalsbericht 2023-Q1
hinzugefügt 16.05.2026
Spectrum Pharmaceuticals Abschreibung & Amortisation 2011-2026 | SPPI
Abschreibung & Amortisation Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 248 K | 286 K | 261 K | 1.62 M | 28.4 M | 28 M | 26.5 M | 31.9 M | 25.4 M | 22.1 M | 12.2 M | 5.65 M | 4.51 M | 4.24 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 31.9 M | 248 K | 13.7 M |
Abschreibung & Amortisation Vierteljährlich Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45 K | - | 200 K | 147 K | 73 K | - | 212 K | 138 K | 65 K | - | -105 K | 282 K | 140 K | - | 1.49 M | 1.4 M | 1.33 M | - | 21 M | 14 M | 7 M | - | 21 M | 14 M | 6.98 M | - | 19.5 M | 12.5 M | 6.01 M | - | 21.2 M | 14.1 M | 7.02 M | - | 18.7 M | 12.2 M | 5.98 M | - | 16.2 M | 6.62 M | 3.27 M | - | 6.71 M | 4.04 M | 1.67 M | - | 3.99 M | 2.48 M | 1.15 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.2 M | -105 K | 6.83 M |
Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler
| Name | Abschreibung & Amortisation | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Coherus BioSciences
CHRS
|
1.3 M | $ 1.63 | -1.52 % | $ 191 M | ||
|
Happiness Biotech Group Limited
HAPP
|
380 K | - | 1.35 % | $ 17.8 M | ||
|
Celldex Therapeutics
CLDX
|
3.38 M | $ 31.56 | -0.44 % | $ 2.1 B | ||
|
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
AstraZeneca PLC
AZN
|
5.73 B | - | - | $ 96.9 B | ||
|
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | ||
|
Compugen Ltd.
CGEN
|
475 K | $ 2.69 | -3.42 % | $ 251 M | ||
|
Galera Therapeutics
GRTX
|
20 K | - | -32.59 % | $ 7.61 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | ||
|
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
4.93 M | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
5 K | - | -4.36 % | $ 27 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
1.74 M | - | - | $ 384 M | ||
|
Gracell Biotechnologies
GRCL
|
58.8 M | - | - | $ 3.37 B | ||
|
Anika Therapeutics
ANIK
|
5.37 M | $ 14.71 | -1.26 % | $ 211 M | ||
|
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | ||
|
CRISPR Therapeutics AG
CRSP
|
19.5 M | $ 55.8 | -1.03 % | $ 5.02 B | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.36 | - | $ 5.53 M | ||
|
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
7.72 M | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
700 K | $ 21.47 | 0.14 % | $ 2.73 B | ||
|
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M |